Trial Profile
Post marketing prospective study of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Jul 2017 Status changed from recruiting to completed.
- 22 Jul 2016 New trial record